Characterization of resistant MCF-7 breast cancer cells developed by repeated cycles of photodynamic therapy
Breast cancer mainly affects women and causes a severe global threat to health. It is often managed and treated with surgery, chemotherapy, immunotherapy, and radiation therapy. Generally, chemotherapy as a treatment option is often opposed by responsive tumor relapse and development of resistance,...
Saved in:
Main Authors: | Eric Chekwube Aniogo (Author), Blassan P. George (Author), Heidi Abrahamse (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dicoma anomala Enhances Phthalocyanine Mediated Photodynamic Therapy in MCF-7 Breast Cancer Cells
by: Alexander Chota, et al.
Published: (2022) -
Conjugation of Hypericin to Gold Nanoparticles for Enhancement of Photodynamic Therapy in MCF-7 Breast Cancer Cells
by: Dimakatso Mokoena, et al.
Published: (2022) -
Understanding the Photodynamic Therapy Induced Bystander and Abscopal Effects: A Review
by: Kave Moloudi, et al.
Published: (2023) -
Inorganic Nanoparticles Applied for Active Targeted Photodynamic Therapy of Breast Cancer
by: Hanieh Montaseri, et al.
Published: (2021) -
Photodynamic therapy of lung cancer, where are we?
by: Anine Crous, et al.
Published: (2022)